Eko, creators of a machine learning-based heart and lung monitoring platform, announced a collaboration with Mayo Clinic to develop a data-driven technology to help physicians detect potentially dangerous heart diseases that may otherwise be missed. The two entities will work together to develop and commercialize a machine learning-based algorithm with a smart digital stethoscope that screens patients for the presence of a low ejection fraction. Once identified, evidence-based treatments are available that prolong life and reduce the risk of symptoms.
Overall cardiology compensation has dropped for the first time since 2014, according to the sixth annual Cardiovascular Provider Compensation & Production Survey from MedAxiom. In addition, the survey found the income gap between private and integrated groups widened in 2017.
October 25, 2018 — On Oct. 18, 2018, LivaNova issued a Medical Device Correction letter to inform customers of actions ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Pre-participation physical evaluations (PPEs) are a standard requirement for many school-aged athletes to participate in competitive sports. One purpose of the PPE is to check for any underlying cardiovascular abnormalities that could put an athlete at risk for sudden cardiac arrest (SCA), which is the number one medical cause of death in young athletes.
Michael Flaherty, M.D., discusses a study published in Circulation Research which finds that use of hemodynamic support ...
For those living with diabetes, monitoring blood glucose accurately is necessary to prevent diabetes-related complications such as heart attacks, blindness and coma. Researchers from the University of Missouri School of Medicine and the Massachusetts Institute of Technology (MIT) recently evaluated the accuracy of an MIT-developed technology to monitor blood glucose levels without needles or a finger prick. Early results show the noninvasive technology measures blood glucose levels as effectively as a finger-prick test — without drawing blood.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Health informatics company Impathiq announced its Heart Pathway point-of-care clinical decision support tool was recently featured in the American Heart Association journal Circulation. The article, “Safely Identifying Emergency Department Patients with Acute Chest Pain for Early Discharge: The HEART Pathway Accelerated Diagnostic Protocol” appeared Sept. 28 in Circulation.
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease risk assessment, according to a new study appearing in the journal Radiology.
Daniel J. Schimmel, Jr., M.D., MS, a cardiologist at Northwestern Memorial Hospital, recently performed the first balloon pulmonary angioplasty (BPA) to treat a pulmonary embolism in the state of Illinois.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
October 19, 2018 — Abbott announced today that the HeartMate 3 Left Ventricular Assist Device (LVAD) has received U.S ...
A picture is worth a thousand words, and to patients concerned about their health, detailed images of the coronary ...
Shimadzu Medical Systems USA and Change Healthcare have entered a partnership through which Shimadzu will offer Change Healthcare Cardiology Hemo, along with its Trinias line of angiography systems. The announcement was made at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21-25 in San Diego.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
October 17, 2018 — The U.S. Food and Drug Administration (FDA) has reviewed information about potential cybersecurity ...
October 17, 2018 — The U.S. Food and Drug Administration (FDA) has cleared an additional indication for rivaroxaban ...
October 16, 2018 — Abbott announced that its High Sensitive Troponin-I blood test has received CE Mark for distribution ...